IL1B and coronary artery disorder: In the past 5 years, more attention has been paid to the mechanism of the inflammasome in coronary heart disease (84), and the NLRP3 inflammasome-driven IL-1 release has led to atherosclerotic progression and accelerated vascular inflammatory response (85, 86).